WALKER ROBERT W

Director Walker buys 5,745 FGBI shares at $4.53 amid -63.5% 52-week decline and -$45.0M net loss

Walker Robert W, Director, purchased 5,745 shares at $4.53 on 2025-12-11, increasing his holdings to 51,121 shares (+12.7% from prior level of 45,376 shares). This buy occurs against deteriorating stock fundamentals: the company reported net income of -$45,003,000.00, the stock is down -63.5% from its 52-week high of $13.39, and the current price of $4.89 reflects a -14.5% decline over the past 30 days. Walker's own same-ticker transaction history at FGBI shows a 0% well-timed rate on prior buys—his earlier purchases on 2025-09-11 and 2025-08-28 posted -45.2% and -39.8% 90-day returns respectively—establishing a pattern of poorly-timed entries at this stock. His cross-ticker track record reinforces this pattern: 10 prior open-market buys averaged -25.1% over 90 days with a 0.00% win rate. This purchase appears to follow immediately after another buy on 2025-12-10, suggesting continued accumulation despite deteriorating near-term price action and a long-established pattern of trades that underperform over the measurable period.

Director Walker buys 7,500 FGBI shares at $4.54; stock now $4.70, down 66.7% from 52-week high

WALKER ROBERT W purchased 7,500 shares at $4.54 on 2025-12-10, increasing his holdings to 45,376 shares—a 19.8% increase from his 37,876 share pre-transaction baseline. The current price of $4.70 is -22.8% over the last 30 days and -42.3% over the last 90 days, reflecting a stock in distress and trading at -66.7% from its 52-week high of $14.13. Notably, the company posted net income of -$45,003,000, indicating significant losses, and the purchase occurred amid a dramatic price collapse. Across Walker's cross-ticker history, his 10 prior buy trades averaged -25.1% over 90 days with a 0.00% win rate, and at FGBI specifically, his two measurable prior buys (2025-09-11 and 2025-08-28) produced 90-day returns of -45.2% and -39.8% respectively, with zero of two prior buys at this ticker well-timed at the 90-day mark. This latest purchase, following three additional buys in the past month at FGBI, coincides with sustained operational losses and sustained price pressure.

Director Walker bought 3,600 shares at blended $4.94 across 2 transactions; stock now -70.1% from 52-week high amid $-45.0M net loss.

Walker Robert W, a director at First Guaranty Bancshares, made 2 separate purchases totaling 3,600 shares for $17,784.00 at an average price of $4.94 on November 25 and December 4, 2025, increasing his holdings by +10.5% to 37,876 shares. The current price of $4.41 stands 70.1% below the 52-week high of $14.75, and the stock has declined 23.6% over 30 days and 48.5% over 90 days. Across his prior 5 trades at FGBI, Walker's timing at the 90-day mark has been uniformly unsuccessful: all 4 measurable prior buys at this ticker posted negative 90-day returns ranging from -0.4% to -39.8%, establishing a 0% 90-day win rate at FGBI. The company reports a net loss of $-45,003,000.00, further context that the purchase occurs amid material financial deterioration rather than operational strength.

Director Walker buys 3,000 FGBI shares at $8.20; stock down 45.0% from 52-week high, posting $-7.3M net loss.

Robert W Walker, a director of First Guaranty Bancshares, purchased 3,000 shares at $8.20 on 2025-09-11, increasing his holdings by 9.6% to 34,276 shares. The transaction occurs amid significant headwinds: the stock trades at $8.11, down 45.0% from its 52-week high of $14.75, and the company recently posted a net loss of $-7.3M. Walker's prior five trades at this same ticker have been consecutive buys over the past three months, with the most recent four (Aug 25–28 and this purchase on Sep 11) outcomes not yet measurable. His cross-ticker track record shows a 0.00% win rate at the 90-day mark across 6 prior open-market buys, averaging -8.4% returns over 90 days, suggesting limited historical success timing market entries. The consecutive buying pattern and depressed valuation merit attention to whether this reflects informed confidence in a turnaround or opportunistic accumulation despite deteriorating fundamentals.

Director Walker buys 3,750 shares of FGBI at $7.97; stock down -42.9% from 52-week high amid $-7.3M net loss.

Walker purchased 3,750 shares at $7.97 on 2025-08-28, expanding his stake by 13.6% to 31,276 shares total. This marks his third buy in four days (after purchases on 2025-08-25 and 2025-08-27), suggesting sustained accumulation activity. The purchases occur against a deteriorating backdrop: the stock trades at $8.42, down -42.9% from its 52-week high of $14.75, while the company reports a net loss of $-7.3M. At same-ticker FGBI, Walker's prior buy on 2025-05-20 declined -12.2% over 90 days, and his cross-ticker track record shows a 0.00% win rate at the 90-day mark across 5 prior buys. The repetitive buying pattern despite recent underperformance and negative earnings raises a question about whether the director's conviction in a recovery is being tested by fundamental weakness.

Director Walker bought 3,800 shares of FGBI at $8.05 on 2025-08-27; stock now $7.91, -46.4% from $14.75 high.

Director Robert W. Walker purchased 3,800 shares at $8.05 on 2025-08-27, increasing his holdings by 16.0% to 27,526 shares. The stock has declined 11.1% over the past 30 days and trades 46.4% below its 52-week high of $14.75, though the company reported a net loss of $7,303,000.00. Across his same-ticker history at FGBI, Walker has made 5 prior trades, with a 0% win rate at the 90-day mark—his prior measurable sale on 2025-05-20 declined 12.2% over 90 days after purchase. The current purchase occurs within an environment of negative momentum and poor historical execution at this specific ticker.

Director Walker buys 4,700 FGBI shares at $7.84; stock down 46.2% from 52-week high amid net loss of $7.3M.

Director Robert W. Walker purchased 4,700 shares of First Guaranty Bancshares at $7.84 on 2025-08-25, increasing his holdings by 24.8% to 23.6K shares. The timing is notable given significant headwinds: the stock trades at $7.94, down 46.2% from its 52-week high of $14.75, and the company reported a net loss of $7.3M. At FGBI specifically, Walker's prior buy on 2025-05-20 delivered a 90-day return of -12.2%, and his 2025-03-31 purchase yielded -4.7% over 90 days—neither trade was well-timed in retrospect. His cross-ticker record shows 0 wins in 90-day returns across 4 prior buys. The purchase occurs in a depressed price environment, yet Walker's historical pattern suggests difficulty capturing recoveries after entry.

Director Walker buys 8,000 shares of FGBI at $8.10; stock now $8.86, down 39.9% from 52-week high; cluster of 4 other insider buys in past 14 days.

Director Robert W Walker purchased 8,000 shares at $8.10 on 2025-06-30, increasing his holdings by 80.0% to 18,000 shares total. The purchase price sits 2.8% above the 30-day average and 12.4% above the 90-day average, suggesting modest near-term strength in the stock from recent lows. However, the current price of $8.86 reflects a 39.9% decline from the 52-week high of $14.75, and the company is reporting a net loss of $6.2M, which undercuts the fundamental backdrop for this activity. The timing is notable: four other insiders also bought within the past 14 days, creating a cluster pattern. Walker's own prior trades at FGBI show mixed results—his May 2025 purchase has declined 11.2% over 30 days, though his March 2025 purchase gained 11.0% in 30 days before falling 4.7% over 90 days. Cross-ticker, his track record shows zero wins at the 90-day mark across 2 prior buys with an average 90-day return of -4.7%, suggesting limited success timing market entries.

Director Walker bought 3,000 shares of FGBI at $9.12 on 2025-05-20; stock down 38.3% from 52-week high, now trading -12.0% over 30 days.

Director Robert W Walker purchased 3,000 shares at $9.12, increasing his holdings to 10,000 shares (a 42.9% increase). The purchase comes as the stock trades -38.3% from its 52-week high of $14.75 and has declined 12.0% over the past 30 days, though it is up 4.1% over 90 days. Walker's cross-ticker track record shows 1 prior open-market buy with an average 30-day return of +11.0%, and his most recent FGBI purchase on 2025-03-31 also delivered +11.0% in 30 days. However, the company's fundamentals present a conflicting signal: the latest reported net income is -$6,166,000.00 with a P/E of 29.35 on a market cap of $117,284,658.40. The buy occurs against a backdrop of recent price weakness and negative earnings, making the motivation for accumulation at these levels unclear from the available facts.

Director Robert W. Walker buys 6,000 shares of FGBI at $8.47; current price $9.40, down 36.3% from 52-week high of $14.75.

Director Robert W. Walker purchased 6,000 shares at $8.47 on 2025-03-31, establishing a new position with no prior holdings. The purchase occurred when the stock trades at $9.40, near the lower end of its 52-week range ($6.70–$14.75) and down 36.3% from the 52-week high. The company carries a P/E of 7.34 with market cap of $117.5M and reported net income of $1.9M, positioning it as a micro-cap bank trading at a compressed valuation. The transaction represents the entry of a board member into equity ownership at a depressed price point relative to recent history, though the stock has recovered 22.1% in the past 30 days.